Misuse of Drugs Act 1971 (Modification) Order 2003
| Jurisdiction | UK Non-devolved |
| Citation | SI 2003/1243 |
| Year | 2003 |
2003 No. 1243
DANGEROUS DRUGS
The Misuse of Drugs Act 1971 (Modification) Order 2003
Made 8th May 2003
Coming into force 1st July 2003
At the Court at Buckingham Palace, the 8th day of May 2003
Present,
The Queen’s Most Excellent Majesty in Council
Whereas a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and has been approved by a resolution of each House of Parliament;
Now, therefore, Her Majesty, in pursuance of section 2(2) of the Misuse of Drugs Act 19711, is pleased, by and with the advice of Her Privy Council, to order, and it is hereby ordered, as follows:—
1. This Order shall be cited as the Misuse of Drugs Act 1971 (Modification) Order 2003 and shall come into force on 1st July 2003.
2.—(1) Schedule 2 to the Misuse of Drugs Act 19712(which specifies the drugs which are subject to control under that Act) shall be amended as follows:
(2) In paragraph 1(a) of Part I of that Schedule there shall be inserted—
(a)
(a) after “Dihydrocodeinone O-carboxymethyloxime”, “Dihydroetorphine”; and
(b)
(b) after “Racemorphan”, “Remifentanil.”.
(3) In paragraph 1(a) of Part III of that Schedule, there shall be inserted—
(a)
(a) after “Haloxazolam”, “4-Hydroxy-n-butyric acid”; and
(b)
(b) after “N-Ethylamphetamine”, “Zolpidem”.
(4) In paragraph 1(b) of Part III of that Schedule, there shall be inserted—
(a)
(a) before “Atamestane”, “4-Androstene-3, 17-dione” and “5-Androstene-3, 17-diol”; and
(b)
(b) after “Nandrolone”, “19-Nor-4-Androstene-3, 17-dione”; and “19-Nor-5-Androstene-3, 17-diol”.
A. K. Galloway
Clerk of the Privy Council
(This note is not part of the Order)
This Order adds eight substances to Schedule 2 to the Misuse of Drugs Act 1971 which specifies drugs which are subject to control under the Act. Two of the substances, Dihydroetorphine and Remifentanil, are added as Class A drugs; and the remaining six, 4-Androstene-3, 17-dione; 5-Androstene-3, 17-diol; 4-Hydroxy-n-butyric acid; 19-Nor-4-Androstene-3; 17-dione, 19-Nor-5-Androstene-3, 17-diol and Zolpidem, are added as Class C drugs.
To continue reading
Request your trial